Nervous system → peripheral nerve → recording question → computer.
Can a future bounded observation keep its true biological source through detection, artifact handling, classification, and computation?
Limen asks whether a system could observe a signal from a peripheral nerve and deliver a requested signal back without the two being confused, and without a command ever being mistaken for proof of delivery or effect.
ILLUSTRATIVE AMBIENT GEOMETRY — NOT DEVICE GEOMETRY OR SELECTED ARCHITECTURE
Neither sequence is anatomy, geometry, circuitry, placement, or a procedure.
Nervous system → peripheral nerve → recording question → computer.
Can a future bounded observation keep its true biological source through detection, artifact handling, classification, and computation?
Computer → stimulation question → afferent peripheral nerve → nervous system.
Can requested, authorized, delivered, measured, and reported-effect states stay separate? A command is not proof of delivery or of biological effect.
The accepted record contains explanatory material and logical drawings for the concept. Acceptance covers those files only. It does not extend to implementation, engineering inputs, or physical development.
Manifest, checksums, traceability data, open parameters, and controls for the exact accepted files.
A bounded explanation of an information-boundary and transmitter-connector question.
Logical drawings accepted only inside the concept record. They are not fabrication drawings.
A software-only synthetic approach and a non-biological bench approach are proposed. Neither exists.
BUILD AUTHORITY WITHHELD. An earlier bench proposal failed review and remains rejected and unaccepted. Its corrected revision also remains unaccepted. No part, topology, value, drawing, wiring, or assembly step has standing as an authorized build.
Five input records have been reviewed and accepted. Closing an input record means the documentation is complete for this stage. It does not change the accepted concept, select any architecture, authorize implementation, or change the overall status of REVISION. Release is not authorized.
Product owns a source-neutral synthetic envelope whose values are assumed for a future bench and not selected. Measured-output and passive-load records are kept distinct. Biological applicability stays blocked. No device, product, or architecture is chosen.
The science overlay keeps route and signal-class lineage and proposes freezing population, function, endpoint, schedule, exposure, and duration before any future comparator search. It adds no new sources, values, or adjudication and establishes no biological capability.
Ten decisions about a future isolated runtime are recorded in the abstract: language, serialization, seed lineage, scheduling, resource admission, filesystem and network containment, audit, and policy identity. All ten remain unselected. The implementation gap remains open. No implementation exists.
A legal, regulatory, and ethics record maps research-only intended use and enhancement boundaries while keeping conventional, biohybrid, and combined options neutral. It supplies no legal advice, classification, ethics approval, regulatory path, freedom-to-operate conclusion, or clearance.
The business record selects no branch and keeps the commercial gap OPEN or BLOCKED. It establishes no feasibility, availability, program, or market authorization.
Input closure is documentation only.
No actual engineering-ready physical device, practical blueprint, or authorized build.
No selected components, parts, topology, circuitry, materials, dimensions, tolerances, fabrication, procurement, assembly, or energization.
No biological interface, implantation, biological protocol, animal work, human work, or clinical use.
No safety, efficacy, feasibility, novelty, freedom-to-operate, readiness, availability, or superiority conclusion.
No development program, executable LIMEN runtime, device control, testing authority, deployment, publication, or release.
Limen is accepted as a concept only. Engineering inputs are closed as records only. Overall status remains REVISION and release is not authorized. No interface, implant, prosthesis, clinical system, biological protocol, or development program is represented here.